Literature DB >> 18492798

The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor.

Linhao Li1, Tao Chen, Joseph D Stanton, Tatsuya Sueyoshi, Masahiko Negishi, Hongbing Wang.   

Abstract

As a promiscuous xenobiotic sensor, the constitutive androstane receptor (CAR; NR1I3) regulates the expression of multiple drug-metabolizing enzymes and transporters in liver. The constitutively activated nature of CAR in the cell-based transfection assays has hindered its use as a predictor of metabolism-based drug-drug interactions. Here, we have identified 1-(2-chlorophenylmethylpropyl)-3-isoquinoline-carboxamide (PK11195), a typical peripheral benzodiazepine receptor (PBR) ligand, as a selective and potent inhibitor of human (h) CAR. In cell-based transfection assays, PK11195 inhibited the constitutive activity of hCAR more than 80% at the concentration of 10 microM, and the PK11195-inhibited activity was efficiently reactivated by the direct CAR activator, 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl) oxime, but not by the indirect hCAR activator, phenobarbital. Mammalian two-hybrid and GST pull-down assays showed that PK11195 repressed the interactions of hCAR with the coactivators steroid receptor coactivator-1 and glucocorticoid receptor-interacting protein 1 to inhibit hCAR activity. The inhibition by PK11195 specifically occurred to the hCAR: PK1195 strongly activated human pregnane X receptor (PXR), whereas it did not alter the activity of the mouse CAR and mouse PXR. In addition, PBR played no role in the PK11195 inhibition of hCAR because the inhibition fully occurred in the HeLa cells in which the PBR was knocked down by small interfering RNA. In the Car(-/-) mouse liver, PK11195 translocated enhanced yellow fluorescent protein-hCAR into the nucleus. These results are consistent with the conclusion that PK11195 is a novel hCAR-specific antagonist that represses the CAR-coactivator interactions to inhibit the receptor activity inside the nucleus. Thus, PK11195 can be used as a chemical tool for studying the molecular basis of CAR function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492798      PMCID: PMC2562670          DOI: 10.1124/mol.108.046656

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

1.  A novel drug-regulated gene expression system based on the nuclear receptor constitutive androstane receptor (CAR).

Authors:  P Honkakoski; I Jääskeläinen; M Kortelahti; A Urtti
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

2.  Direct expression of fluorescent protein-tagged nuclear receptor CAR in mouse liver.

Authors:  Tatsuya Sueyoshi; Rick Moore; Jean-Marc Pascussi; Masahiko Negishi
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

3.  The role of the nuclear receptor CAR as a coordinate regulator of hepatic gene expression in defense against chemical toxicity.

Authors:  Yukio Yamamoto; Takeshi Kawamoto; Masahiko Negishi
Journal:  Arch Biochem Biophys       Date:  2003-01-01       Impact factor: 4.013

4.  Xenobiotic induction of cytochrome P450 2B1 (CYP2B1) is mediated by the orphan nuclear receptor constitutive androstane receptor (CAR) and requires steroid co-activator 1 (SRC-1) and the transcription factor Sp1.

Authors:  R Muangmoonchai; D Smirlis; S C Wong; M Edwards; I R Phillips; E A Shephard
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

5.  Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR.

Authors:  Jun Zhang; Wendong Huang; Steven S Chua; Ping Wei; David D Moore
Journal:  Science       Date:  2002-10-11       Impact factor: 47.728

6.  Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene.

Authors:  T Kawamoto; S Kakizaki; K Yoshinari; M Negishi
Journal:  Mol Endocrinol       Date:  2000-11

7.  Residue threonine 350 confers steroid hormone responsiveness to the mouse nuclear orphan receptor CAR.

Authors:  Akiko Ueda; Satoru Kakizaki; Masahiko Negishi; Tatsuya Sueyoshi
Journal:  Mol Pharmacol       Date:  2002-06       Impact factor: 4.436

8.  The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR.

Authors:  J Sugatani; H Kojima; A Ueda; S Kakizaki; K Yoshinari; Q H Gong; I S Owens; M Negishi; T Sueyoshi
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

9.  Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands.

Authors:  Andrea Toell; Klaus-Dietrich Kröncke; Hartmut Kleinert; Carsten Carlberg
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

10.  The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver.

Authors:  I Zelko; T Sueyoshi; T Kawamoto; R Moore; M Negishi
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

View more
  56 in total

1.  Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands.

Authors:  Ann M Dring; Linnea E Anderson; Saima Qamar; Matthew A Stoner
Journal:  Chem Biol Interact       Date:  2010-10-20       Impact factor: 5.192

2.  Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells.

Authors:  Leslie Tompkins; Caitlin Lynch; Sam Haidar; James Polli; Hongbing Wang
Journal:  Pharm Res       Date:  2010-05-26       Impact factor: 4.200

Review 3.  Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.

Authors:  Antonia H Tolson; Hongbing Wang
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

4.  Molecular Basis of Metabolism-Mediated Conversion of PK11195 from an Antagonist to an Agonist of the Constitutive Androstane Receptor.

Authors:  Bryan Mackowiak; Linhao Li; Matthew A Welch; Daochuan Li; Jace W Jones; Scott Heyward; Maureen A Kane; Peter W Swaan; Hongbing Wang
Journal:  Mol Pharmacol       Date:  2017-04-25       Impact factor: 4.436

Review 5.  Small-molecule modulators of the constitutive androstane receptor.

Authors:  Milu T Cherian; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-05-15       Impact factor: 4.481

6.  Identification of novel activators of constitutive androstane receptor from FDA-approved drugs by integrated computational and biological approaches.

Authors:  Caitlin Lynch; Yongmei Pan; Linhao Li; Stephen S Ferguson; Menghang Xia; Peter W Swaan; Hongbing Wang
Journal:  Pharm Res       Date:  2012-10-23       Impact factor: 4.200

7.  Indirect activation of the SV23 and SV24 splice variants of human constitutive androstane receptor: analysis with 3-hydroxyflavone and its analogues.

Authors:  Aik Jiang Lau; Thomas K H Chang
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

8.  Flame retardant BDE-47 effectively activates nuclear receptor CAR in human primary hepatocytes.

Authors:  Tatsuya Sueyoshi; Linhao Li; Hongbing Wang; Rick Moore; Prasada Rao S Kodavanti; Hans-Joachim Lehmler; Masahiko Negishi; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2013-11-11       Impact factor: 4.849

9.  Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation.

Authors:  Yoshihiro Konno; Susumu Kodama; Rick Moore; Nobuhiro Kamiya; Masahiko Negishi
Journal:  Mol Pharmacol       Date:  2008-11-03       Impact factor: 4.436

Review 10.  Targeting xenobiotic receptors PXR and CAR for metabolic diseases.

Authors:  Jie Gao; Wen Xie
Journal:  Trends Pharmacol Sci       Date:  2012-08-10       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.